Last reviewed · How we verify
NCT03387124
Breastfeeding Study
trial testing Breastfed infants in Infant Term Birth in 75 participants. Completed in 11 December 2018.
24 October 2018
Quick facts
| Lead sponsor | Société des Produits Nestlé (SPN) |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 75 |
| Start date | 22 January 2018 |
| Primary completion | 24 October 2018 |
| Estimated completion | 11 December 2018 |
| Sites | 1 location across Philippines |
Drugs / interventions tested
- Breastfed infants
Conditions studied
- Infant Term Birth — all drugs for Infant Term Birth →
Sponsor
Société des Produits Nestlé (SPN) — full company profile →
Who can join
Adults 21 Days to 26 Days, any sex, with Infant Term Birth. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the stool consistency and microbiota composition of healthy breastfed infants.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial.
Estorninos E, Lawenko RB, Palestroque E, Sprenger N, et al · · 2022 · cited 39× · PMID 34617558 · DOI 10.1093/ajcn/nqab336 -
Dynamics of human milk oligosaccharides in early lactation and relation with growth and appetitive traits of Filipino breastfed infants.
Samuel TM, Hartweg M, Lebumfacil JD, Buluran KB, et al · · 2022 · cited 12× · PMID 36243744 · DOI 10.1038/s41598-022-22244-7 -
Dynamics of Human Milk Oligosaccharides in early lactation and relation with growth and appetitive traits of Filipino breastfed infants
Samuel TM, Hartweg M, Lebumfacil JD, Buluran KB, et al · · 2022 · DOI 10.21203/rs.3.rs-1621019/v1
Verify or expand the search:
- PubMed search for NCT03387124
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Société des Produits Nestlé (SPN) trials
Trials by the same sponsor.
- NCT07312201 — Oral Nutritional Supplementation in Children With Growth Concerns · NA · not yet recruiting
- NCT07378111 — Vegetarian Tube Feed Study · NA · not yet recruiting
- NCT07439718 — The Effects of an Oral Nutritional Intervention on the Small Intestine Microbiome · NA · recruiting
- NCT07341464 — Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends · NA · recruiting
- NCT07127198 — Tolerance and Appetite Reduction of a Nutritional Solution With Intragastric Gelation Properties · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03387124 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Société des Produits Nestlé (SPN)
- Last refreshed: 24 April 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03387124.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing